drugset / Trial / NCT06400719
Pilot Study of AVT16 in Healthy Adult Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot study in healthy adult subjects to evaluate the safety and tolerability of AVT16 after administration of a single intravenous administration. Pharmacokinetics and immunogenicity of AVT16 will also be evaluated.
Timeline
- Start
- 2024-05-29
- Primary completion
- 2024-11-06
- Completion
- 2024-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVT16 | Unknown | 300 mg | Intravenous |
Indications
No indication recorded.